Characterization of hepatic cellular uptake of [alpha]1-acid glycoprotein (AGP), part 2: Involvement of hemoglobin [beta]-chain on plasma membranes in the uptake of human AGP by liver parenchymal cells

• Published in: Journal of pharmaceutical sciences 2012-04, Vol.101 (4), p.1607
• Main Authors: Komori, Hisakazu, Nishi, Koji, Uehara, Nao, Watanabe, Hiroshi, Shuto, Tsuyoshi, Suenaga, Ayaka, Maruyama, Toru, Otagiri, Masaki
• Format: Article
• Language: English
• ISSN: 0022-3549; 1520-6017
• DOI: 10.1002/jps.23015

Human [alpha]1-acid glycoprotein (AGP), a lipocalin family member, serves as a carrier for basic drugs and endogenous hormones. It is mainly distributed in the liver and also has anti-inflammatory effects. We previously discovered a protein in liver parenchymal cells that interacts with AGP and it was identified as hemoglobin [beta]-chain (HBB). The purpose of this study was to clarify the role of HBB in the hepatic cellular uptake of AGP. Ligand blotting experiments showed that the interaction of 125I-AGP with hemoglobin was saturable and was significantly suppressed in the presence of excess unlabeled AGP. In addition, the cellular uptake of fluorescein isothiocianate-AGP by HepG2 cells was saturable and temperature dependent. This uptake was inhibited by fillipin and methyl-[beta]-cyclodextrin, but not chlorpromazine, suggesting that AGP is taken up via caveolae/lipid rafts endocytic pathway. Immunostaining showed that HBB and caveolin-1, exclusively expressed in caveolae, were partially colocalized on the plasma membranes of HepG2 cells. HBB knockdown with siRNA decreased the uptake of AGP by HepG2 cells by 40%, and exogenous hemoglobin inhibited the uptake by 40%-50%. These findings indicate that HBB is located on the liver plasma membrane and that it contributes to the intracellular uptake of AGP. © 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:1607-1615, 2012 [PUBLICATION ABSTRACT]